Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. It also offers medi...
Zhejiang Shapuaisi Pharmaceutical reported revenue of 462.78 million CNY for fiscal year 2025, down 4.4% from fiscal year 2024, and net income of -238.72 million CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 98.52 million CNY, down 3.2% from a year before. Its largest business segment, Sale of Merchandise, brought in 71% of segment revenue in fiscal year 2025.
Figures from company filings; latest fiscal year ended December 31, 2025.
No profile data available.